Iryna A Khasabova Selected Research

Cannabinoids

3/2015	Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.
12/2014	JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
10/2013	Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain.
5/2012	Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iryna A Khasabova Research Topics

Disease

13	Hyperalgesia 05/2022 - 09/2007
10	Pain (Aches) 05/2022 - 10/2008
10	Neoplasms (Cancer) 12/2020 - 09/2007
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 05/2012
5	Fibrosarcoma 10/2013 - 09/2007
3	Bone Neoplasms (Bone Cancer) 12/2020 - 10/2008
3	Cancer Pain 10/2013 - 07/2011
2	Neuralgia (Stump Neuralgia) 01/2021 - 03/2019
2	Painful Neuropathy 03/2019 - 03/2015
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2019
1	Chronic Pain 12/2014

Drug/Important Bio-Agent (IBA)

7	EndocannabinoidsIBA 05/2022 - 10/2008
5	Opioid Analgesics (Opioids)IBA 05/2022 - 07/2011
5	anandamide (arachidonylethanolamide)IBA 03/2015 - 10/2008
4	Cisplatin (Platino)FDA LinkGeneric 03/2019 - 05/2012
4	CannabinoidsIBA 03/2015 - 05/2012
3	EnzymesIBA 05/2022 - 10/2008
3	CB2 Cannabinoid ReceptorIBA 12/2014 - 07/2011
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2013 - 10/2008
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 05/2022 - 01/2019
2	Dinoprostone (PGE2)FDA Link 05/2022 - 01/2019
2	hemoglobin AAIBA 05/2022 - 01/2019
2	JZL 184IBA 05/2022 - 12/2014
2	ProstaglandinsIBA 05/2022 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 05/2022 - 03/2015
2	EstersIBA 05/2022 - 05/2012
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 09/2011 - 10/2008
2	Proteins (Proteins, Gene)FDA Link 07/2011 - 10/2008
2	Messenger RNA (mRNA)IBA 10/2008 - 09/2007
1	Sickle HemoglobinIBA 05/2022
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 05/2022
1	AntioxidantsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 12/2020
1	resolvin D1IBA 12/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2020
1	Pioglitazone (Actos)FDA Link 03/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2019
1	CalciumIBA 03/2019
1	Arachidonic Acid (Vitamin F)IBA 01/2019
1	purinoceptor P2Y6IBA 01/2019
1	Flurbiprofen (Froben)FDA LinkGeneric 01/2019
1	PlatinumIBA 03/2015
1	CholesterolIBA 10/2013
1	GW 7647IBA 09/2012
1	GW 6471IBA 09/2012
1	5-phenylpentyl N- ((2S,3R)- 2- methyl- 4- oxo- oxetan- 3- yl)carbamateIBA 09/2012
1	AcidsIBA 05/2012
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2011
1	Cannabinoid Receptor AgonistsIBA 09/2011
1	AM 1241IBA 09/2011
1	arachidonylcyclopropylamideIBA 09/2011
1	Glycerol (Glycerine)FDA LinkGeneric 07/2011
1	Morphine (MS Contin)FDA LinkGeneric 07/2011
1	CC ChemokinesIBA 09/2007
1	Gabapentin (Neurontin)FDA LinkGeneric 09/2007
1	Peptides (Polypeptides)IBA 09/2007
1	Capsaicin (Zostrix)FDA Link 09/2007
1	LigandsIBA 09/2007

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 05/2012
1	Intravenous Injections 05/2022
1	Therapeutics 10/2013
1	Injections 05/2012
1	Analgesia 09/2011